The HCPLive ADHD condition center page is a comprehensive resource for clinical news and insights on ADHD. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for ADHD.
September 12th 2024
In an interview, lead investigator Lauren Moran, MD, shared how the results inform clinical practice on safe amphetamine dosing.
September 12th 2024
ADHD May Be Over-Diagnosed in Children with Autism
Simple diagnostic tools like yes-or-no questions lack the nuance required to keep autistic children from being misdiagnosed with attention deficit hyperactivity disorder, according to a new report from the Children's Hospital of Philadelphia.
Prenatal Vitamin D Could Lower Baby's ADHD Risk, While Some Diabetes Drugs May do the Opposite
While one study found that taking vitamin D during pregnancy may hinder early ADHD symptoms, another recent study believes that gestational use of diabetes medications may lead to them.
Focusing on Behavior to Help Children with ADHD Complete Homework
Behavioral treatment impacted the children's homework completion and accuracy, researchers found, "whereas long-acting stimulant medication resulted in limited and largely nonsignificant acute effects on homework performance."
Heredity an Important Factor in ADHD, Alcoholism, and Binge Eating
“We have shown for the first time that the correlation between ADHD symptoms and binge eating in women depends mainly on a common hereditary susceptibility for the two disorders,†Johansson Capusan explained. “Much of the correlation between alcohol dependence and ADHD can also be explained by genetic factors."
Children with ADHD Avoided Punishment while Playing Games
Children with attention deficit hyperactivity disorder (ADHD) may be more sensitive to the cumulative effects of punishment than typically developing children, according to according to findings published in the Journal of Child Psychology and Psychiatry.
Manisha Madhoo from Shire Pharmaceuticals: Meeting the Unmet Needs of ADHD Patients
As the diagnosis process for adults with ADHD becomes more commonplace in medicine today there is still a gap in finding effective treatments to help patients with the condition from childhood to adulthood.
Persistent Parental Criticism and Ongoing ADHD Symptoms
March 31st 2016Persistent parental criticism appears to be among the reasons why attention deficit hyperactivity disorder (ADHD) symptoms persist with age among some children, as opposed to decreasing with age as seen with many children with ADHD.
Prenatal Antidepressant Exposure Not Linked to Autism, ADHD
January 20th 2016Researchers from Massachusetts General Hospital who analyzed medical records from three healthcare systems in their state have found no evidence to indicate that prenatal exposure to antidepressants increases the risk for autism and related disorders or for ADHD.
Children of Chemically Intolerant Mothers at Risk for Autism and ADHD
August 17th 2015Study results published in the July-August 2015 issue of the Journal of the American Board of Family Medicine suggest a potential association between maternal chemical intolerance and a diagnosis of attention deficit hyperactivity disorder (ADHD) or autism spectrum disorder (ASD) in their offspring.
Does Altitude Affect ADHD Risk?
April 16th 2015In contrast to recent studies linking patients who reside in higher elevations with increased rates of depression and suicide, a new study suggests that the prevalence of attention-deficit hyperactivity disorder appears to decrease as altitude increases.
Evaluating an ADHD Drug As a Potential Treatment for Binge Eating Disorder
Lisdexamfetamine dimesylate, a medication approved for ADHD treatment, was assessed for its efficacy in managing binge eating disorder. In some doses, this approach was effective in 4-week binge eating cessation.
ADHD May Stem from Slower Brain Network Connectivity
The brains of children and adolescents with attention deficit hyperactivity disorder (ADHD) are slower to develop some key connections, according to a study published in the Proceedings of the National Academy of Sciences.
FDA Approves Celgene's PDE4 Inhibitor Otezla for the Treatment of Plaque Psoriasis in Adults
September 23rd 2014Otezla (apremilast) is an oral, selective phosphodiesterase 4 (PDE4) inhibitor for the treatment of patients with moderate to severe plaque psoriasis for whom phototherapy or systemic therapy is appropriate.